|Juno Therapeutics Inc -- USA Stock|| |
USD 86.96 0.01 0.0115%
Juno Therapeutics Inc retains Coefficient Of Variation
of 634.8, Market Risk Adjusted Performance
of 0.4798 and Risk Adjusted Performance
of 0.1575. Juno Therapeutics technical analysis makes it possible for you to employ historical prices
and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found eighteen technical drivers
for Juno Therapeutics Inc which can be compared to its competitors. Please check out Juno Therapeutics Inc Variance
, Value At Risk
as well as the relationship
between Value At Risk and Skewness
to decide if Juno Therapeutics is priced fairly providing market reflects its last-minute price of 86.96 per share. Given that Juno Therapeutics Inc has Treynor Ratio
of 0.4698, we strongly advise you confirm Juno Therapeutics Inc regular market performance to make sure the company can sustain itself at future point.
Juno Therapeutics Inc Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Juno Therapeutics Inc Trend Analysis
Use this graph to draw trend lines for Juno Therapeutics Inc. You can use it to identify possible trend reversals for Juno Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Juno Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Juno Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Juno Therapeutics Inc applied against its price change over selected period. The best fit line has a slop of 0.098922 %
which means Juno Therapeutics Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 7.98, which is the sum of squared deviations for the predicted Juno Therapeutics price change compared to its average price change.